News
Ascendis Pharma A/S (Nasdaq: ASND) today announced three oral presentations of its latest achondroplasia and hypoparathyroidism data at ASBMR 2025, the annual meeting of the American Society for Bone ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback